November 20, 2019
Robert Harrington, MD
Arthur L. Bloomfield Professor of Medicine
Stanford University
President, American Heart Association
Via email: rharring@stanford.edu
Dear Dr. Harrington:
On November 15, you
reported that the American Heart Association launched a “game-changing
research initiative” that “will help us answer critical questions about the
health consequences of vaping and nicotine addiction…” You emphasized an issue important to every
health professional and parent: youth e-cigarette use. And you used an especially relevant but
ironic hashtag: #QuitLying.
Your flagship publication, the Journal of the American Heart
Association, on June 5, 2019, published a bogus research article, “Electronic
cigarette use and myocardial infarction among adults in the US Population
Assessment of Tobacco and Health [PATH],” by Dharma N. Bhatta and Stanton A.
Glantz (here).
Drs. Bhatta and Glantz claimed that e-cigarette use caused
heart attacks. However, at least 11 of the 38 current e-cigarette users in
their study had a heart attack years
before they first started using
e-cigarettes.
The article in your journal presents falsified results on
e-cigarettes and deliberately omits obvious and important information about participants’
ages at first heart attack and first e-cigarette. The article represents a significant
departure from accepted research practices.
I wrote to you with details about the false results on July
11 and July 18, and I urged you to consider an investigation and
retraction.
You failed to provide a substantive response (here)
to my letters. The “game-changing”
research question you need to answer about “about the health consequences of
vaping” is how e-cigarettes can cause a heart attack many years before people
use them.
An organization committed to #QuitLying about e-cigarettes
has a professional and moral obligation to adhere to its own principles. In failing to investigate and address false
research, the American Heart Association invites scrutiny pursuant to its own
hashtag.
Respectfully,
Brad Rodu
No comments:
Post a Comment